STRATA Ebitda vs Research Development Analysis

SSKN Stock

USD 0.36 0.02 5.26%

STRATA Skin financial indicator trend analysis is much more than just breaking down STRATA Skin Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether STRATA Skin Sciences is a good investment. Please check the relationship between STRATA Skin Ebitda and its Research Development accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Ebitda vs Research Development

Ebitda vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of STRATA Skin Sciences Ebitda account and Research Development. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between STRATA Skin's Ebitda and Research Development is -0.7. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Research Development in the same time period over historical financial statements of STRATA Skin Sciences, assuming nothing else is changed. The correlation between historical values of STRATA Skin's Ebitda and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of STRATA Skin Sciences are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Ebitda i.e., STRATA Skin's Ebitda and Research Development go up and down completely randomly.

Correlation Coefficient

-0.7

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Ebitda

Research Development

Most indicators from STRATA Skin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into STRATA Skin Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

As of the 6th of June 2024, Enterprise Value is likely to grow to about 34.2 M, while Selling General Administrative is likely to drop about 8.9 M.

STRATA Skin fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Non Current Assets Total	Common Stock Shares Outstanding	Total Current Assets	Other Stockholder Equity	Non Currrent Assets Other	Other Current Assets	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Net Debt	Cash	Cash And Short Term Investments	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Other Assets	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Preferred Stock Total Equity
Total Assets		0.73	-0.77	0.86	0.59	0.52	0.83	0.15	-0.04	0.73	0.6	0.44	0.72	0.27	0.21	0.21	0.57	0.61	0.69	0.13	0.9	0.18	0.5	0.31	0.21	-0.57
Total Stockholder Equity	0.73		-0.57	0.39	0.48	0.85	0.68	0.09	0.32	0.16	0.1	0.28	0.45	-0.37	0.73	0.72	0.1	0.51	0.33	0.4	0.44	0.34	-0.16	0.05	-0.07	-0.65
Retained Earnings	-0.77	-0.57		-0.76	-0.59	-0.37	-0.92	0.03	-0.01	-0.69	-0.59	-0.57	-0.68	-0.36	-0.07	-0.07	-0.68	-0.54	-0.6	-0.13	-0.76	-0.29	-0.3	-0.61	-0.47	0.83
Non Current Assets Total	0.86	0.39	-0.76		0.53	0.09	0.67	0.06	-0.17	0.93	0.77	0.45	0.6	0.67	-0.21	-0.21	0.83	0.5	0.79	-0.21	0.95	-0.03	0.74	0.36	0.46	-0.42
Common Stock Shares Outstanding	0.59	0.48	-0.59	0.53		0.5	0.48	-0.25	-0.27	0.55	0.09	0.88	0.78	0.06	0.2	0.2	0.39	0.96	0.23	0.25	0.67	0.47	0.07	0.25	0.51	-0.28
Total Current Assets	0.52	0.85	-0.37	0.09	0.5		0.45	0.21	0.21	0.02	-0.08	0.31	0.39	-0.56	0.88	0.88	-0.1	0.51	0.01	0.69	0.21	0.43	-0.31	0.02	-0.03	-0.51
Other Stockholder Equity	0.83	0.68	-0.92	0.67	0.48	0.45		0.0	0.07	0.51	0.48	0.41	0.69	0.19	0.17	0.17	0.47	0.49	0.61	0.17	0.73	0.31	0.22	0.54	0.16	-0.82
Non Currrent Assets Other	0.15	0.09	0.03	0.06	-0.25	0.21	0.0		-0.14	0.11	0.19	-0.47	-0.23	-0.02	0.23	0.23	0.09	-0.26	0.26	0.25	0.0	-0.32	0.3	0.07	-0.05	-0.1
Other Current Assets	-0.04	0.32	-0.01	-0.17	-0.27	0.21	0.07	-0.14		-0.31	-0.09	-0.15	-0.25	-0.42	0.38	0.38	-0.05	-0.21	-0.11	-0.15	-0.27	0.47	-0.34	-0.12	-0.18	-0.47
Total Liab	0.73	0.16	-0.69	0.93	0.55	0.02	0.51	0.11	-0.31		0.8	0.53	0.57	0.76	-0.3	-0.3	0.87	0.48	0.66	-0.15	0.88	-0.03	0.81	0.43	0.64	-0.32
Short Long Term Debt Total	0.6	0.1	-0.59	0.77	0.09	-0.08	0.48	0.19	-0.09	0.8		0.1	0.3	0.77	-0.26	-0.26	0.81	0.03	0.65	-0.18	0.67	-0.16	0.78	0.23	0.48	-0.42
Other Current Liab	0.44	0.28	-0.57	0.45	0.88	0.31	0.41	-0.47	-0.15	0.53	0.1		0.71	0.15	0.03	0.04	0.39	0.87	0.01	0.05	0.57	0.52	0.07	0.37	0.54	-0.26
Total Current Liabilities	0.72	0.45	-0.68	0.6	0.78	0.39	0.69	-0.23	-0.25	0.57	0.3	0.71		0.25	-0.03	-0.03	0.41	0.79	0.38	0.34	0.72	0.45	0.15	0.42	0.23	-0.39
Net Debt	0.27	-0.37	-0.36	0.67	0.06	-0.56	0.19	-0.02	-0.42	0.76	0.77	0.15	0.25		-0.78	-0.78	0.73	-0.02	0.54	-0.4	0.55	-0.37	0.8	0.36	0.47	0.01
Cash	0.21	0.73	-0.07	-0.21	0.2	0.88	0.17	0.23	0.38	-0.3	-0.26	0.03	-0.03	-0.78		1.0	-0.3	0.22	-0.2	0.53	-0.11	0.33	-0.46	-0.3	-0.12	-0.37
Cash And Short Term Investments	0.21	0.72	-0.07	-0.21	0.2	0.88	0.17	0.23	0.38	-0.3	-0.26	0.04	-0.03	-0.78	1.0		-0.29	0.22	-0.2	0.53	-0.11	0.33	-0.46	-0.29	-0.11	-0.37
Property Plant And Equipment Net	0.57	0.1	-0.68	0.83	0.39	-0.1	0.47	0.09	-0.05	0.87	0.81	0.39	0.41	0.73	-0.3	-0.29		0.3	0.63	-0.28	0.73	0.06	0.68	0.26	0.78	-0.46
Current Deferred Revenue	0.61	0.51	-0.54	0.5	0.96	0.51	0.49	-0.26	-0.21	0.48	0.03	0.87	0.79	-0.02	0.22	0.22	0.3		0.19	0.2	0.65	0.52	0.05	0.26	0.33	-0.26
Accounts Payable	0.69	0.33	-0.6	0.79	0.23	0.01	0.61	0.26	-0.11	0.66	0.65	0.01	0.38	0.54	-0.2	-0.2	0.63	0.19		-0.2	0.73	-0.12	0.62	0.3	0.23	-0.38
Other Assets	0.13	0.4	-0.13	-0.21	0.25	0.69	0.17	0.25	-0.15	-0.15	-0.18	0.05	0.34	-0.4	0.53	0.53	-0.28	0.2	-0.2		-0.11	0.15	-0.44	0.07	-0.15	-0.24
Net Receivables	0.9	0.44	-0.76	0.95	0.67	0.21	0.73	0.0	-0.27	0.88	0.67	0.57	0.72	0.55	-0.11	-0.11	0.73	0.65	0.73	-0.11		0.09	0.68	0.34	0.46	-0.38
Common Stock Total Equity	0.18	0.34	-0.29	-0.03	0.47	0.43	0.31	-0.32	0.47	-0.03	-0.16	0.52	0.45	-0.37	0.33	0.33	0.06	0.52	-0.12	0.15	0.09		-0.37	0.18	0.15	-0.44
Non Current Liabilities Total	0.5	-0.16	-0.3	0.74	0.07	-0.31	0.22	0.3	-0.34	0.81	0.78	0.07	0.15	0.8	-0.46	-0.46	0.68	0.05	0.62	-0.44	0.68	-0.37		0.22	0.38	0.01
Inventory	0.31	0.05	-0.61	0.36	0.25	0.02	0.54	0.07	-0.12	0.43	0.23	0.37	0.42	0.36	-0.3	-0.29	0.26	0.26	0.3	0.07	0.34	0.18	0.22		0.09	-0.47
Property Plant And Equipment Gross	0.21	-0.07	-0.47	0.46	0.51	-0.03	0.16	-0.05	-0.18	0.64	0.48	0.54	0.23	0.47	-0.12	-0.11	0.78	0.33	0.23	-0.15	0.46	0.15	0.38	0.09		-0.24
Preferred Stock Total Equity	-0.57	-0.65	0.83	-0.42	-0.28	-0.51	-0.82	-0.1	-0.47	-0.32	-0.42	-0.26	-0.39	0.01	-0.37	-0.37	-0.46	-0.26	-0.38	-0.24	-0.38	-0.44	0.01	-0.47	-0.24

Click cells to compare fundamentals

STRATA Skin Account Relationship Matchups

STRATA Skin fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	27.2M	33.6M	34.1M	34.7M	34.9M	36.7M
Other Current Liab	4.5M	4.7M	6.4M	6.9M	6.4M	6.7M
Accounts Payable	1.8M	2.8M	2.8M	3.4M	3.3M	2.5M
Other Assets	428K	347K	1.3M	216K	248.4K	301.5K
Property Plant Equipment	5.3M	5.4M	6.5M	7.5M	8.6M	4.7M
Other Liab	499K	178K	288K	666K	765.9K	1.1M
Net Tangible Assets	12.7M	11.9M	10.7M	6.5M	5.9M	6.7M
Retained Earnings Total Equity	(229.4M)	(210.8M)	(214.6M)	(219.0M)	(197.1M)	(206.9M)
Capital Surpluse	251.6M	242.0M	243.2M	244.8M	281.6M	235.9M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in STRATA Stock

When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:

How To Invest In STRATA

Details

Is STRATA Stock a good investment?

Details

What is STRATA Skin's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.33)

Revenue Per Share

0.931

Quarterly Revenue Growth

(0.11)

Return On Assets

(0.09)

Return On Equity

(0.79)

The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

STRATA Ebitda vs Research Development Analysis

Ebitda vs Research Development

Ebitda vs Research Development Correlation Analysis

Correlation Coefficient

Ebitda

Research Development

STRATA Skin fundamental ratios Correlations

STRATA Skin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

STRATA Skin fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Additional Information and Resources on Investing in STRATA Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Current Deferred Revenue	+ 0.96	Common Stock Shares Outstanding
Net Receivables	+ 0.95	Non Current Assets Total
Total Liab	+ 0.93	Non Current Assets Total
Net Receivables	+ 0.9	Total Assets
Other Current Liab	+ 0.88	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.92	Retained Earnings
Preferred Stock Total Equity	- 0.82	Other Stockholder Equity
Cash And Short Term Investments	- 0.78	Net Debt
Cash	- 0.78	Net Debt
Retained Earnings	- 0.77	Total Assets
Net Receivables	- 0.76	Retained Earnings